Table 1.
Contrast | Cohort size | Reference | Organism |
---|---|---|---|
MASH F2 vs. MASLD |
MASH = 153 MASLD = 53 |
64 | Human |
MASH F3 vs. MASLD | |||
MASH F3 vs. MASH F0/1 | |||
MASH F4 vs. MASLD | |||
MASH F4 vs. MASH F0/1 | |||
MASLD vs. CTRL |
MASLD = 27 MASH = 25 CTRL = 39 |
65 | |
MASH vs. CTRL (1) | |||
MASLD stage 4 vs. CTRL |
MASLD = 72 CTRL = 6 |
66 | |
MASLD stage 5 vs. CTRL | |||
MASLD stage 6 vs. CTRL | |||
MASH vs. CTRL (2) |
MASH = 16 CTRL = 14 |
42 | |
HFD 30 vs. CTRL |
HFD = 5 CTRL = 5 |
65 | Mouse |
MCD 8 vs. CTRL |
MCD = 10 CTRL = 5 |
||
HFD+STZ 18 vs. CTRL |
HFD+STZ = 5 CTRL = 4 |
||
WD vs. CTRL |
WD = 5 CTRL = 5 |
||
APAP vs. CTRL |
APAP = 44 CTRL = 5 |
66 | |
CCl4 vs. CTRL (Acute) |
CCl4 = 41 CTRL = 5 |
||
CCl4 vs. CTRL (Chronic) |
CCl4 = 18 CTRL = 18 |
||
TM vs. CTRL |
TM = 4 CTRL = 3 |
||
MASH vs. CTRL (1) |
MASH = 9 CTRL = 4 |
68 | |
MASH vs. CTRL (2) |
MASH = 3 CTRL = 3 |
67 | |
CYP51 LKO vs. CTRL |
CYP51 = 3 CTRL = 3 |
69 | |
GLMP KO vs. CTRL |
GLMP = 4 CTRL = 4 |
||
IKBKG LKO vs. CTRL |
IKBKG = 3 CTRL = 3 |
||
RBPJ LKO vs. CTRL |
RBPJ = 3 CTRL = 4 |
||
WD+CCl4 (MASH) vs. CTRL |
MASH = 17 CTRL = 9 |
Present study |
Numbers after diet (HFD 30, MCD 8) correspond to number of weeks. MASLD stages 4–6 correspond to NAFLD activity score (NAS).
MASLD metabolic dysfunction-associated steatotic liver disease, MASH metabolic dysfunction-associated steatohepatitis, CTRL control, SHH sonic hedgehog, HFD high-fat diet, MCD methionine- and choline-deficient diet, STZ streptozocin, WD western diet, APAP acetaminophen, CCl4 carbon tetrachloride, TM tunicamycin, KO knockout, LKO liver knockout, CYP51 cytochrome P450 lanosterol 14α-demethylase, GLMP glycosylated lysosomal membrane protein, IKBKG inhibitor of kappa B kinase gamma, RBPJ recombination signal binding protein for immunoglobulin kappa J region.